Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Your provider may adjust based on your medical history
Tesamorelin selectively reduces visceral fat by 15 to 18 percent while preserving subcutaneous fat, a targeted redistribution not achievable through caloric restriction alone
SOLAN, BADDI HIMACHAL PRADESH 103505 Country of origin: INDIA Expiry on or after: December 2026 In case of any issues, contact us: Was this product description useful
PubMed Randomized trialTirzepatide evidence2022 Tirzepatide Once Weekly for the Treatment of Obesity Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability
US$ 26.62
US$ 20.52
US$ 25.17
US$ 29.76
US$ 28.62
US$ 26.32
US$ 20.73
US$ 23.02
US$ 29.55
